Regulation of multidrug resistance in pathogenic fungi.

[1]  C. Bauser,et al.  Functional Analysis of cis- and trans-Acting Elements of the Candida albicans CDR2 Promoter with a Novel Promoter Reporter System , 2009, Eukaryotic Cell.

[2]  A. Sellam,et al.  Role of Ndt80p in Sterol Metabolism Regulation and Azole Resistance in Candida albicans , 2009, Eukaryotic Cell.

[3]  B. Da Silva,et al.  Nonsense and Missense Mutations in FCY2 and FCY1 Genes Are Responsible for Flucytosine Resistance and Flucytosine-Fluconazole Cross-Resistance in Clinical Isolates of Candida lusitaniae , 2009, Antimicrobial Agents and Chemotherapy.

[4]  G. Boucher,et al.  Identification of the Candida albicans Cap1p Regulon , 2009, Eukaryotic Cell.

[5]  J. Piškur,et al.  Formation of new chromosomes as a virulence mechanism in yeast Candida glabrata , 2009, Proceedings of the National Academy of Sciences.

[6]  M. Raymond,et al.  Relative Contributions of the Candida albicans ABC Transporters Cdr1p and Cdr2p to Clinical Azole Resistance , 2009, Antimicrobial Agents and Chemotherapy.

[7]  G. Fadda,et al.  Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence , 2009, PLoS pathogens.

[8]  D. Choudhury,et al.  MFS transportome of the human pathogenic yeast Candida albicans , 2008, BMC Genomics.

[9]  Lan Yan,et al.  DNA microarray analysis of fluconazole resistance in a laboratory Candida albicans strain. , 2008, Acta biochimica et biophysica Sinica.

[10]  R. Cannon,et al.  Abc1p Is a Multidrug Efflux Transporter That Tips the Balance in Favor of Innate Azole Resistance in Candida krusei , 2008, Antimicrobial Agents and Chemotherapy.

[11]  Martin Bard,et al.  A Sterol-Regulatory Element Binding Protein Is Required for Cell Polarity, Hypoxia Adaptation, Azole Drug Resistance, and Virulence in Aspergillus fumigatus , 2008, PLoS pathogens.

[12]  P. D. Rogers,et al.  Gain-of-Function Mutations in the Transcription Factor MRR1 Are Responsible for Overexpression of the MDR1 Efflux Pump in Fluconazole-Resistant Candida dubliniensis Strains , 2008, Antimicrobial Agents and Chemotherapy.

[13]  J. Morschhäuser,et al.  Mutations in the multi‐drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole‐resistant Candida albicans strains , 2008, Molecular microbiology.

[14]  R. Homayouni,et al.  A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans Isolate , 2008, Eukaryotic Cell.

[15]  M. Ramsdale,et al.  Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae. , 2008, Microbiology.

[16]  J. Berman,et al.  An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1 , 2008, Molecular microbiology.

[17]  T. C. White,et al.  Characterization of caspofungin susceptibilities by broth and agar in Candida albicans clinical isolates with characterized mechanisms of azole resistance. , 2008, Medical mycology.

[18]  K. Struhl,et al.  A nuclear receptor-like pathway regulating multidrug resistance in fungi , 2008, Nature.

[19]  G. Fadda,et al.  The ATP‐binding cassette transporter–encoding gene CgSNQ2 is contributing to the CgPDR1‐dependent azole resistance of Candida glabrata , 2008, Molecular microbiology.

[20]  M. Treiber,et al.  Rifampicin induces MDR1 expression in Candida albicans. , 2008, The Journal of antimicrobial chemotherapy.

[21]  R. Prasad,et al.  Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression of CDR1 in Azole-Resistant Candida albicans , 2008, Antimicrobial Agents and Chemotherapy.

[22]  Hao Li,et al.  The Evolution of Combinatorial Gene Regulation in Fungi , 2008, PLoS biology.

[23]  A. Stringaro,et al.  Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicans , 2008, Antimicrobial Agents and Chemotherapy.

[24]  J. Yates,et al.  CTA4 Transcription Factor Mediates Induction of Nitrosative Stress Response in Candida albicans , 2007, Eukaryotic Cell.

[25]  R. Homayouni,et al.  The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans , 2007, PLoS pathogens.

[26]  Sadri Znaidi,et al.  The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans , 2007, Molecular microbiology.

[27]  R. Homayouni,et al.  Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon , 2007, Eukaryotic Cell.

[28]  Kailash Gulshan,et al.  Multidrug Resistance in Fungi , 2007, Eukaryotic Cell.

[29]  D. Diogo,et al.  Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates , 2007, Eukaryotic Cell.

[30]  D. Perlin.  Resistance to echinocandin-class antifungal drugs. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[31]  Y. Uehara,et al.  Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression in Saccharomyces cerevisiae , 2007, Eukaryotic Cell.

[32]  R. Prasad,et al.  Voriconazole and multidrug resistance in Candida albicans , 2007, Mycoses.

[33]  J. Bennett,et al.  The bZip transcription factor Cgap1p is involved in multidrug resistance and required for activation of multidrug transporter gene CgFLR1 in Candida glabrata. , 2007, Gene.

[34]  C. Hennequin,et al.  Reduced Susceptibility to Polyenes Associated with a Missense Mutation in the ERG6 Gene in a Clinical Isolate of Candida glabrata with Pseudohyphal Growth , 2006, Antimicrobial Agents and Chemotherapy.

[35]  D. Sanglard,et al.  Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance. , 2006, Microbiology.

[36]  J. Villard,et al.  Molecular Mechanism of Flucytosine Resistance in Candida lusitaniae: Contribution of the FCY2, FCY1, and FUR1 Genes to 5-Fluorouracil and Fluconazole Cross-Resistance , 2006, Antimicrobial Agents and Chemotherapy.

[37]  C. Kumamoto,et al.  Transcriptional Regulation of MDR1, Encoding a Drug Efflux Determinant, in Fluconazole-Resistant Candida albicans Strains through an Mcm1p Binding Site , 2006, Eukaryotic Cell.

[38]  B. Turcotte,et al.  A Fungal Family of Transcriptional Regulators: the Zinc Cluster Proteins , 2006, Microbiology and Molecular Biology Reviews.

[39]  R. Homayouni,et al.  Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome‐wide expression studies , 2006, Molecular microbiology.

[40]  J. Berman,et al.  Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans , 2006, Science.

[41]  J. Morschhäuser,et al.  Multiple cis-Acting Sequences Mediate Upregulation of the MDR1 Efflux Pump in a Fluconazole-Resistant Clinical Candida albicans Isolate , 2006, Antimicrobial Agents and Chemotherapy.

[42]  M. Raymond,et al.  PDR16‐mediated azole resistance in Candida albicans , 2006, Molecular microbiology.

[43]  J. Berman,et al.  A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans , 2006, Genetics.

[44]  J. Bennett,et al.  Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants , 2006, Antimicrobial Agents and Chemotherapy.

[45]  D. Sanglard,et al.  Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans , 2006, Antimicrobial Agents and Chemotherapy.

[46]  R. Cannon,et al.  Overexpression of Candida albicans CDR1, CDR2, or MDR1 Does Not Produce Significant Changes in Echinocandin Susceptibility , 2006, Antimicrobial Agents and Chemotherapy.

[47]  G. Fadda,et al.  Role of AFR1, an ABC Transporter-Encoding Gene, in the In Vivo Response to Fluconazole and Virulence of Cryptococcus neoformans , 2006, Infection and Immunity.

[48]  D. Choudhury,et al.  Complete Inventory of ABC Proteins in Human Pathogenic Yeast, Candida albicans , 2005, Journal of Molecular Microbiology and Biotechnology.

[49]  F. Dalle,et al.  Biological consequences of petite mutations in Candida glabrata. , 2005, The Journal of antimicrobial chemotherapy.

[50]  R. Vishwakarma,et al.  Functional Analysis of CaIPT1, a Sphingolipid Biosynthetic Gene Involved in Multidrug Resistance and Morphogenesis of Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.

[51]  W. Moye-Rowley.  Retrograde regulation of multidrug resistance in Saccharomyces cerevisiae. , 2005, Gene.

[52]  T. C. White,et al.  Drug-Induced Regulation of the MDR1 Promoter in Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.

[53]  R. Prasad,et al.  Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element. , 2005, Biochemical and biophysical research communications.

[54]  R. Homayouni,et al.  Genome-Wide Expression Profiling of the Response to Azole, Polyene, Echinocandin, and Pyrimidine Antifungal Agents in Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.

[55]  A. Mitchell,et al.  Regulation of azole drug susceptibility by Candida albicans protein kinase CK2 , 2005, Molecular microbiology.

[56]  S. Kelly,et al.  Reduced Azole Susceptibility in Genotype 3 Candida dubliniensis Isolates Associated with Increased CdCDR1 and CdCDR2 Expression , 2005, Antimicrobial Agents and Chemotherapy.

[57]  G. Fadda,et al.  Mechanisms of Azole Resistance in Clinical Isolates of Candida glabrata Collected during a Hospital Survey of Antifungal Resistance , 2005, Antimicrobial Agents and Chemotherapy.

[58]  B. Arthington-Skaggs,et al.  Rapid Acquisition of Stable Azole Resistance by Candida glabrata Isolates Obtained before the Clinical Introduction of Fluconazole , 2005, Antimicrobial Agents and Chemotherapy.

[59]  T. Edlind,et al.  Effects of Cetylpyridinium Chloride Resistance and Treatment on Fluconazole Activity versus Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.

[60]  J. Vazquez,et al.  Multiechinocandin- and Multiazole-Resistant Candida parapsilosis Isolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis , 2005, Antimicrobial Agents and Chemotherapy.

[61]  D. Sanglard,et al.  TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2 , 2004, Eukaryotic Cell.

[62]  Y. Uehara,et al.  Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance. , 2004, The Journal of antimicrobial chemotherapy.

[63]  Yun-Liang Yang,et al.  CaNdt80 Is Involved in Drug Resistance in Candida albicans by Regulating CDR1 , 2004, Antimicrobial Agents and Chemotherapy.

[64]  L. Tabernero,et al.  Molecular Mechanisms of Primary Resistance to Flucytosine in Candida albicans , 2004, Antimicrobial Agents and Chemotherapy.

[65]  G. Goldman,et al.  In Vitro Evolution of Itraconazole Resistance in Aspergillus fumigatus Involves Multiple Mechanisms of Resistance , 2004, Antimicrobial Agents and Chemotherapy.

[66]  T. Edlind,et al.  Azole Resistance in Candida glabrata: Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor , 2004, Antimicrobial Agents and Chemotherapy.

[67]  G. Goldman,et al.  Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil. , 2004, Diagnostic microbiology and infectious disease.

[68]  Alix T. Coste,et al.  Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug Transporters , 2004, Antimicrobial Agents and Chemotherapy.

[69]  D. Soll,et al.  Clade-Specific Flucytosine Resistance Is Due to a Single Nucleotide Change in the FUR1 Gene of Candida albicans , 2004, Antimicrobial Agents and Chemotherapy.

[70]  P. Poupard,et al.  Mechanisms of Azole Resistance in Petite Mutants of Candida glabrata , 2004, Antimicrobial Agents and Chemotherapy.

[71]  K. Marr,et al.  Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis , 2004, Antimicrobial Agents and Chemotherapy.

[72]  B. Cormack,et al.  Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata: Roles of Calcium Signaling and Mitochondria , 2004, Antimicrobial Agents and Chemotherapy.

[73]  R. Prasad,et al.  Membrane Sphingolipid-Ergosterol Interactions Are Important Determinants of Multidrug Resistance in Candida albicans , 2004, Antimicrobial Agents and Chemotherapy.

[74]  Steve A. Hernandez,et al.  Caspofungin Resistance in Candida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis , 2004, Antimicrobial Agents and Chemotherapy.

[75]  J. Sobel,et al.  Shuttle vectors for Candida albicans: control of plasmid copy number and elevated expression of cloned genes , 2004, Current Genetics.

[76]  N. Karnani,et al.  SRE1 and SRE2 are two specific steroid‐responsive modules of Candida drug resistance gene 1 (CDR1) promoter , 2004, Yeast.

[77]  Mi-Kyung Lee,et al.  Drug resistance genes and trailing growth in Candida albicans isolates. , 2004, The Journal of antimicrobial chemotherapy.

[78]  T. Edlind,et al.  Cyclic AMP Signaling Pathway Modulates Susceptibility of Candida Species and Saccharomyces cerevisiae to Antifungal Azoles and Other Sterol Biosynthesis Inhibitors , 2003, Antimicrobial Agents and Chemotherapy.

[79]  J. Heitman,et al.  Disruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B in Candida lusitaniae , 2003, Antimicrobial Agents and Chemotherapy.

[80]  M. Raymond,et al.  Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters , 2003, Antimicrobial Agents and Chemotherapy.

[81]  G. Goldman,et al.  Multiple Resistance Mechanisms among Aspergillus fumigatus Mutants with High-Level Resistance to Itraconazole , 2003, Antimicrobial Agents and Chemotherapy.

[82]  K. Kuchler,et al.  The Candida albicans Cdr2p ATP‐binding cassette (ABC) transporter confers resistance to caspofungin , 2003, Molecular microbiology.

[83]  P. Paumard,et al.  Flucytosine-Fluconazole Cross-Resistance in Purine-Cytosine Permease-Deficient Candida lusitaniae Clinical Isolates: Indirect Evidence of a Fluconazole Uptake Transporter , 2003, Antimicrobial Agents and Chemotherapy.

[84]  J. Bennett,et al.  Function of Candida glabrata ABC transporter gene, PDH1 , 2003, Yeast.

[85]  H. Brunner,et al.  A screen in Saccharomyces cerevisiae identified CaMCM1, an essential gene in Candida albicans crucial for morphogenesis , 2003, Molecular microbiology.

[86]  J. Lopez-Ribot,et al.  Multiple Patterns of Resistance to Fluconazole in Candida glabrata Isolates from a Patient with Oropharyngeal Candidiasis Receiving Head and Neck Radiation , 2003, Journal of Clinical Microbiology.

[87]  G. Fadda,et al.  Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter‐encoding gene, CnAFR1, involved in the resistance to fluconazole , 2003, Molecular microbiology.

[88]  Y. Uehara,et al.  Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[89]  R. Skurray,et al.  Regulation of Bacterial Drug Export Systems , 2002, Microbiology and Molecular Biology Reviews.

[90]  Y. Uehara,et al.  Candida glabrata ATP-binding Cassette Transporters Cdr1p and Pdh1p Expressed in aSaccharomyces cerevisiae Strain Deficient in Membrane Transporters Show Phosphorylation-dependent Pumping Properties* , 2002, The Journal of Biological Chemistry.

[91]  T. Edlind,et al.  Histone Deacetylase Inhibitors Enhance Candida albicans Sensitivity to Azoles and Related Antifungals: Correlation with Reduction in CDR and ERG Upregulation , 2002, Antimicrobial Agents and Chemotherapy.

[92]  J. Morschhäuser,et al.  The Candida dubliniensis CdCDR1 Gene Is Not Essential for Fluconazole Resistance , 2002, Antimicrobial Agents and Chemotherapy.

[93]  D. Denning,et al.  Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. , 2002, Fungal genetics and biology : FG & B.

[94]  J. Morschhäuser.  The genetic basis of fluconazole resistance development in Candida albicans. , 2002, Biochimica et biophysica acta.

[95]  B. Wickes,et al.  Molecular Mechanisms of Fluconazole Resistance in Candida dubliniensis Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis , 2002, Antimicrobial Agents and Chemotherapy.

[96]  R. Prasad,et al.  In Vitro Low-Level Resistance to Azoles in Candida albicans Is Associated with Changes in Membrane Lipid Fluidity and Asymmetry , 2002, Antimicrobial Agents and Chemotherapy.

[97]  T. C. White,et al.  Homozygosity at the Candida albicans MTL locus associated with azole resistance. , 2002, Microbiology.

[98]  Smriti,et al.  ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators , 2002, Yeast.

[99]  J. Lopez-Ribot,et al.  Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis. , 2002, The Journal of antimicrobial chemotherapy.

[100]  D. Sanglard,et al.  A common drug‐responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance , 2002, Molecular microbiology.

[101]  J. Morschhäuser,et al.  MDR1-Mediated Drug Resistance inCandida dubliniensis , 2001, Antimicrobial Agents and Chemotherapy.

[102]  J. Lopez-Ribot,et al.  Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients , 2001, Antimicrobial Agents and Chemotherapy.

[103]  M. Raymond,et al.  Functional isolation of the Candida albicans FCR3 gene encoding a bZip transcription factor homologous to Saccharomyces cerevisiae Yap3p , 2001, Yeast.

[104]  Xiao-Jun Ma,et al.  Genomic Profiling of the Response of Candida albicans to Itraconazole Treatment Using a DNA Microarray , 2001, Antimicrobial Agents and Chemotherapy.

[105]  D. Sanglard,et al.  Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in Candida glabrata , 2001, Antimicrobial Agents and Chemotherapy.

[106]  S. Katiyar,et al.  Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei. , 2001, Medical mycology.

[107]  T. C. White,et al.  Inducible Azole Resistance Associated with a Heterogeneous Phenotype in Candida albicans , 2001, Antimicrobial Agents and Chemotherapy.

[108]  R. Filmon,et al.  In-vivo selection of an azole-resistant petite mutant of Candida glabrata. , 2000, Journal of Medical Microbiology.

[109]  D. Sanglard,et al.  A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. , 2000, Microbiology.

[110]  T. C. White,et al.  Transcriptional Analyses of Antifungal Drug Resistance in Candida albicans , 2000, Antimicrobial Agents and Chemotherapy.

[111]  D. Sanglard,et al.  Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750 , 2000, Antimicrobial Agents and Chemotherapy.

[112]  H. Schoonbeek,et al.  Fungal transporters involved in efflux of natural toxic compounds and fungicides. , 2000, Fungal genetics and biology : FG & B.

[113]  J. Morschhäuser,et al.  Targeted gene disruption in Candida albicans wild‐type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates , 2000, Molecular microbiology.

[114]  D. Sanglard,et al.  Analysis of the oxidative stress regulation of the Candida albicans transcription factor, Cap1p , 2000, Molecular microbiology.

[115]  L. Cowen,et al.  Evolution of Drug Resistance in Experimental Populations of Candida albicans , 2000, Journal of bacteriology.

[116]  G. Köhler,et al.  Activation of the Multiple Drug Resistance GeneMDR1 in Fluconazole-Resistant, Clinical Candida albicans Strains Is Caused by Mutations in atrans-Regulatory Factor , 2000, Journal of bacteriology.

[117]  T. C. White,et al.  The R467K Amino Acid Substitution in Candida albicans Sterol 14α-Demethylase Causes Drug Resistance through Reduced Affinity , 2000, Antimicrobial Agents and Chemotherapy.

[118]  D. Kelly,et al.  Y132H substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem. , 1999, FEMS microbiology letters.

[119]  D. Sanglard,et al.  The ATP Binding Cassette Transporter GeneCgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents , 1999, Antimicrobial Agents and Chemotherapy.

[120]  R. V. Prasad,et al.  CDR1, a multidrug resistance gene from Candida albicans, contains multiple regulatory domains in its promoter and the distal AP-1 element mediates its induction by miconazole. , 1999, FEMS microbiology letters.

[121]  M. Ghannoum,et al.  Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance , 1999, Clinical Microbiology Reviews.

[122]  J. Morschhäuser,et al.  Molecular aspects of fluconazole resistance development in Candida albicans , 1999, Mycoses.

[123]  D. Kelly,et al.  The G464S amino acid substitution in Candida albicans sterol 14alpha-demethylase causes fluconazole resistance in the clinic through reduced affinity. , 1999, Biochemical and biophysical research communications.

[124]  S. Katiyar,et al.  Antagonism of Azole Activity against Candida albicans following Induction of Multidrug Resistance Genes by Selected Antimicrobial Agents , 1999, Antimicrobial Agents and Chemotherapy.

[125]  J. Lopez-Ribot,et al.  Multiple Resistant Phenotypes of Candida albicansCoexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients , 1999, Antimicrobial Agents and Chemotherapy.

[126]  P. Staib,et al.  Sequential gene disruption in Candida albicans by FLP‐mediated site‐specific recombination , 1999, Molecular microbiology.

[127]  M. Raymond,et al.  The bZip Transcription Factor Cap1p Is Involved in Multidrug Resistance and Oxidative Stress Response inCandida albicans , 1999, Journal of bacteriology.

[128]  V. Gupta,et al.  Asymmetric distribution of phosphatidylethanolamine in C. albicans : possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily , 1999, Yeast.

[129]  A. Goffeau,et al.  PDR16 and PDR17, Two Homologous Genes ofSaccharomyces cerevisiae, Affect Lipid Biosynthesis and Resistance to Multiple Drugs* , 1999, The Journal of Biological Chemistry.

[130]  M. Raymond,et al.  Isolation of a Putative Candida albicansTranscriptional Regulator Involved in Pleiotropic Drug Resistance by Functional Complementation of a pdr1 pdr3 Mutation inSaccharomyces cerevisiae , 1999, Journal of bacteriology.

[131]  L H Lee,et al.  Crm1p mediates regulated nuclear export of a yeast AP‐1‐like transcription factor , 1998, The EMBO journal.

[132]  D. Kelly,et al.  Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical Candida albicans Strains , 1998, Antimicrobial Agents and Chemotherapy.

[133]  T. C. White,et al.  Distinct Patterns of Gene Expression Associated with Development of Fluconazole Resistance in Serial Candida albicansIsolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis , 1998, Antimicrobial Agents and Chemotherapy.

[134]  J. Morschhäuser,et al.  A fourth gene from the Candida albicans CDR family of ABC transporters. , 1998, Gene.

[135]  T. C. White,et al.  Rapid, Transient Fluconazole Resistance inCandida albicans Is Associated with Increased mRNA Levels of CDR , 1998, Antimicrobial Agents and Chemotherapy.

[136]  M. Ghannoum,et al.  Mechanism of Fluconazole Resistance inCandida krusei , 1998, Antimicrobial Agents and Chemotherapy.

[137]  V. Gupta,et al.  Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation , 1998, Current Genetics.

[138]  S. Donnelly,et al.  Identification and Expression of Multidrug Transporters Responsible for Fluconazole Resistance in Candida dubliniensis , 1998, Antimicrobial Agents and Chemotherapy.

[139]  D. Ward,et al.  Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1, inCandida glabrata , 1998, Antimicrobial Agents and Chemotherapy.

[140]  C. Nombela,et al.  Induced expression of the Candida albicans multidrug resistance gene CDR1 in response to fluconazole and other antifungals , 1998, Yeast.

[141]  R. V. Prasad,et al.  Expression of CDR1, a multidrug resistance gene of Candida albicans: transcriptional activation by heat shock, drugs and human steroid hormones. , 1998, FEMS microbiology letters.

[142]  Dominique Sanglard,et al.  Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents , 1998, Antimicrobial Agents and Chemotherapy.

[143]  M. Raymond,et al.  The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter , 1997, Journal of bacteriology.

[144]  P. Skatrud,et al.  Cloning and characterization of CneMDR1: a Cryptococcus neoformans gene encoding a protein related to multidrug resistance proteins. , 1997, Gene.

[145]  P. Skatrud,et al.  Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus. , 1997, Gene.

[146]  A. Goffeau,et al.  Active efflux by multidrug transporters as one of the strategies to evade chemotherapy and novel practical implications of yeast pleiotropic drug resistance. , 1997, Pharmacology & therapeutics.

[147]  C. van Broeckhoven,et al.  Molecular biological characterization of an azole-resistant Candida glabrata isolate , 1997, Antimicrobial agents and chemotherapy.

[148]  M. Raymond,et al.  AP1-mediated Multidrug Resistance in Saccharomyces cerevisiae Requires FLR1 Encoding a Transporter of the Major Facilitator Superfamily* , 1997, The Journal of Biological Chemistry.

[149]  T. C. White,et al.  Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus , 1997, Antimicrobial agents and chemotherapy.

[150]  D. Kelly,et al.  Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363. , 1997, FEMS microbiology letters.

[151]  D. Sanglard,et al.  Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. , 1997, Microbiology.

[152]  D. Kelly,et al.  Resistance to fluconazole and cross‐resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6‐desaturation , 1997, FEBS letters.

[153]  J. Wingard,et al.  Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia , 1997, Antimicrobial agents and chemotherapy.

[154]  R. Cannon,et al.  Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance , 1996, Antimicrobial agents and chemotherapy.

[155]  S. Kelly,et al.  Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance , 1996, Antimicrobial agents and chemotherapy.

[156]  D. Sanglard,et al.  Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors , 1996, Antimicrobial agents and chemotherapy.

[157]  N. Gow,et al.  Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance , 1996, Antimicrobial agents and chemotherapy.

[158]  K. Kuchler,et al.  Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters , 1995, Antimicrobial agents and chemotherapy.

[159]  S. Kelly,et al.  Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug. , 1995, FEMS microbiology letters.

[160]  T. Parkinson,et al.  Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata , 1995, Antimicrobial agents and chemotherapy.

[161]  S. Kelly,et al.  Cross-resistance to polyene and azole drugs in Cryptococcus neoformans , 1995, Antimicrobial agents and chemotherapy.

[162]  A. Goffeau,et al.  Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals , 1995, Current Genetics.

[163]  P. Marichal,et al.  Origin of differences in susceptibility of Candida krusei to azole antifungal agents , 1995, Mycoses.

[164]  A. Oppenheim,et al.  Multidrug resistance in Candida albicans: disruption of the BENr gene , 1995, Antimicrobial agents and chemotherapy.

[165]  S. Sternberg.  The emerging fungal threat. , 1994, Science.

[166]  S. Kelly,et al.  Resistance to amphotericin B associated with defective sterol delta 8-->7 isomerase in a Cryptococcus neoformans strain from an AIDS patient. , 1994, FEMS microbiology letters.

[167]  J. Becker,et al.  Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene , 1994, Antimicrobial Agents and Chemotherapy.

[168]  P. Troke,et al.  Fluconazole resistance in Candida glabrata , 1993, Antimicrobial Agents and Chemotherapy.

[169]  J. A. Gorman,et al.  Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate , 1991, Molecular and General Genetics MGG.

[170]  N. Karnani,et al.  Identification of a negative regulatory element which regulates basal transcription of a multidrug resistance gene CDR1 of Candida albicans. , 2004, FEMS yeast research.

[171]  W. Moye-Rowley.  Transcriptional control of multidrug resistance in the yeast Saccharomyces. , 2003, Progress in nucleic acid research and molecular biology.

[172]  E. Pinjon.  Investigation into the molecular mechanisms of itraconazole resistance in Candida dubliniensis , 2003 .

[173]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[174]  J. F. Ryley,et al.  Azole resistance in Candida albicans. , 1984, Sabouraudia.